Close
Help
Need Help?



Biomarkers in Cancer Added to Gale Academic OneFile

Posted Wed, Oct, 03,2012

Libertas is pleased to announce that Biomarkers in Cancer has now been added to Gale's Academic OneFile database.GALE operates more than 600 databases, including the popular InfoTrac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of Biomarkers in Cancer in GALE's Academic OneFile will increase article visibility in North Am...

Continue Reading →

Bioinformatics and Biology Insights Indexing Partners

Posted Wed, Oct, 03,2012

Libertas works continually to increase online visibility for all our journals, and we are pleased to report that Bioinformatics and Biology Insights is now indexed by 26 external online databases and in 10 online directories and search engines.Indexing with so many external databases and directories means that articles published in Bioinformatics and Biology Insights are searchable in many places,...

Continue Reading →

Drug Target Insights Now on JournalTOCs and 9 Other Directories

Posted Tue, Oct, 02,2012

Libertas is pleased to announce that Drug Target Insights is now included in the JournalTOCs (Journal Tables of Contents) directory and content is available through the website now.JournalTOCs contains metadata from over 17,000 journals collected from almost 1,000 international publishers. The directory is free for anyone to browse the latest news, articles, and developments for all journals liste...

Continue Reading →

Air, Soil and Water Research Added to Gale GREENR

Posted Tue, Oct, 02,2012

Libertas is pleased to announce that Air, Soil and Water Research has now been added to Gale's GREENR (Gale Resource on the Environment, Energy, and Natural Resources) database.GALE operates more than 600 databases, including the popular Info Trac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of Air, Soil and Water Research in...

Continue Reading →

Advances in Tumor Virology Added to Gale Health Reference Centre

Posted Tue, Oct, 02,2012

Libertas is pleased to announce that Advances in Tumor Virology has now been added to Gale's Health Reference Centre database.GALE operates more than 600 databases, including the popular Info Trac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of Advances in Tumor Virology in Health Reference Centre will increase article visibi...

Continue Reading →

Cell & Tissue Transplantation & Therapy Now on JournalTOCs and 8 Other Directories

Posted Tue, Oct, 02,2012

Libertas is pleased to announce that Cell & Tissue Transplantation & Therapy is now included in the JournalTOCs (Journal Tables of Contents) directory and content is available through the website now.JournalTOCs contains metadata from over 17,000 journals collected from almost 1,000 international publishers. The directory is free for anyone to browse the latest news, articles, and developm...

Continue Reading →

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
testimonial_image
I was pleased to serve as a peer reviewer for Clinical Medicine Insights: Therapeutics.  Its scope will hopefully blur some of the lines that still exist between clinical and basic science.  The diligence of the editorial staff ensures the review process is fair, fast and very well-organized.  I highly recommend potential authors and reviewers to submit to and review for this journal.
Dr Sharilyn Almodovar (University of Colorado Denver, Aurora, CO, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results